Search

everythinglearnresearchcommunity

for

Search:↓

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Becker's Nevus Syndrome is a rare condition with a skin patch and possible bone and muscle abnormalities, treated mainly for appearance.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Hormones significantly affect skin health, with vitamin D playing a key role.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

A mushroom extract might reduce hair loss and liver damage caused by certain chemotherapy drugs in animals.

Mouse genital development depends on male or female hormones for specific features.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Caffeine can effectively treat hair loss and skin issues.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Hidradenitis suppurativa improves with antiandrogen therapy.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.